Desmoid
Oncology·MeSH: Desmoid Tumors
Prevalence
0.5 / 100K
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| sonalleve | Profound Medical Corp. (PROF) |
Phase 3(1)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| al102 | Immunome Inc. (IMNM) |
Compare drugs
Frequently asked questions
How many drugs are in development for Desmoid?
BioSniper tracks 3 drugs in development for Desmoid across 3 companies.
How many clinical trials target Desmoid?
There are 2 clinical trials targeting Desmoid tracked by BioSniper.
What is the prevalence of Desmoid?
The estimated prevalence of Desmoid is approximately 0.5 per 100,000 population.
Deep-dive into Desmoid
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis